Protea Biosciences Group, Inc. 4

Accession 0001144204-14-008809

CIK 0001335103operating

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 8:47 PM ET

Size

101.8 KB

Accession

0001144204-14-008809

Insider Transaction Report

Form 4

Period: 2006-06-07

Protea Biosciences Group, Inc.NONE

HOSTLER STANLEY

DirectorVice President and Secretary10% Owner

Transactions

Purchase
Common Stock
2012-03-01$1.50/sh+28,766$43,149→ 2,435,093 total(indirect: By Spouse)
Purchase
Common Stock
2011-12-27$2.00/sh+50,000$100,000→ 1,939,599 total
Purchase
Common Stock
2011-12-27$2.00/sh+50,000$100,000→ 1,939,599 total(indirect: By Spouse)
Purchase
Common Stock
2012-03-01$1.50/sh+135,621$203,432→ 2,075,220 total
Purchase
Common Stock
2012-03-01$1.50/sh+83,360$125,040→ 2,158,580 total
Purchase
Common Stock
2012-03-01$1.50/sh+28,766$43,149→ 2,187,346 total
Purchase
Common Stock
2012-03-01$1.50/sh+135,621$203,432→ 2,322,967 total
Purchase
Common Stock
2012-03-01$1.50/sh+135,621$203,432→ 2,322,967 total(indirect: By Spouse)
Purchase
Common Stock
2012-03-01$1.50/sh+83,360$125,040→ 2,406,327 total
Purchase
Common Stock
2012-03-01$1.50/sh+83,360$125,040→ 2,406,327 total(indirect: By Spouse)
Purchase
Common Stock
2012-03-01$1.50/sh+28,766$43,149→ 2,435,093 total
Purchase
Common Stock
2012-07-27$2.00/sh+50,000$100,000→ 2,510,093 total(indirect: By Spouse)
Purchase
Common Stock
2013-04-12$1.00/sh+105,638$105,638→ 2,615,731 total
Award
Stock Option
2008-12-31$72000.00/sh+48,000$3,456,000,000→ 1,069,000 total
Exercise: $1.50From: 2008-12-31Exp: 2018-12-31→ Common Stock (48,000 underlying)
Award
Stock Option
2009-12-31$72000.00/sh+48,000$3,456,000,000→ 1,117,000 total
Exercise: $1.50From: 2009-12-31Exp: 2019-12-31→ Common Stock (48,000 underlying)
Award
Stock Option
2010-09-17$150000.00/sh+100,000$15,000,000,000→ 1,217,000 total
Exercise: $1.50From: 2010-09-17Exp: 2020-09-17→ Common Stock (100,000 underlying)
Award
Stock Option
2010-12-31$72000.00/sh+48,000$3,456,000,000→ 1,265,000 total
Exercise: $1.50From: 2010-12-31Exp: 2020-12-31→ Common Stock (48,000 underlying)
Purchase
Common Stock
2012-07-27$2.00/sh+25,000$50,000→ 2,460,093 total
Purchase
Common Stock
2012-07-27$2.00/sh+50,000$100,000→ 2,510,093 total
Purchase
Common Stock
2013-04-12$1.00/sh+105,638$105,638→ 2,615,731 total(indirect: By Spouse)
Purchase
Common Stock
2013-04-12$1.00/sh+163,923$163,923→ 2,779,654 total
Purchase
Common Stock
2013-04-12$1.00/sh+163,923$163,923→ 2,779,654 total(indirect: By Spouse)
Purchase
Common Stock
2013-04-12$1.00/sh+163,923$163,923→ 2,943,577 total
Purchase
Common Stock
2013-04-12$1.00/sh+105,638$105,638→ 3,049,215 total
Award
Stock Option
2006-06-07$80000.00/sh+100,000$8,000,000,000→ 1,005,000 total
Exercise: $0.80From: 2006-06-07Exp: 2016-06-07→ Common Stock (100,000 underlying)
Award
Stock Option
2007-09-01$24000.00/sh+16,000$384,000,000→ 1,021,000 total
Exercise: $1.50From: 2007-09-01Exp: 2017-09-01→ Common Stock (16,000 underlying)
Award
Stock Option
2011-12-31$24000.00/sh+12,000$288,000,000→ 1,904,000 total
Exercise: $2.00From: 2011-12-31Exp: 2021-12-31→ Common Stock (12,000 underlying)
Purchase
Warrant
2011-05-31$100000.00/sh+50,000$5,000,000,000→ 1,315,000 total
Exercise: $2.00From: 2011-05-31Exp: 2016-05-31→ Common Stock (50,000 underlying)
Purchase
Warrant
2011-08-31$32000.00/sh+16,000$512,000,000→ 1,331,000 total
Exercise: $2.00From: 2011-08-31Exp: 2016-08-31→ Common Stock (16,000 underlying)
Award
Stock Option
2011-09-30$54000.00/sh+36,000$1,944,000,000→ 1,367,000 total
Exercise: $1.50From: 2011-09-30Exp: 2021-09-30→ Common Stock (36,000 underlying)
Purchase
Warrant
2011-12-27$56250.00/sh+25,000$1,406,250,000→ 1,392,000 total
Exercise: $2.25From: 2011-12-27Exp: 2016-12-27→ Common Stock (25,000 underlying)
Purchase
Warrant
2011-12-27$56250.00/sh+25,000$1,406,250,000→ 1,392,000 total(indirect: By Spouse)
Exercise: $2.25From: 2011-12-27Exp: 2016-12-27→ Common Stock (25,000 underlying)
Purchase
Convertible Note
2011-12-20$250000.00/sh+500,000$125,000,000,000→ 1,892,000 total
Exercise: $2.00From: 2011-12-20Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-04-16$140000.00/sh+280,000$39,200,000,000→ 2,184,000 total
Exercise: $0.50From: 2012-04-16Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-04-16$100000.00/sh+200,000$20,000,000,000→ 2,384,000 total
Exercise: $0.50From: 2012-04-16Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-04-16$100000.00/sh+200,000$20,000,000,000→ 2,384,000 total(indirect: By Spouse)
Exercise: $0.50From: 2012-04-16Exp: 2013-05-31→ Common Stock
Purchase
Warrant
2012-07-27$28125.00/sh+12,500$351,562,500→ 2,396,500 total
Exercise: $2.50From: 2012-07-27Exp: 2017-07-27→ Common Stock (12,500 underlying)
Purchase
Warrant
2012-07-27$56250.00/sh+25,000$1,406,250,000→ 2,421,500 total
Exercise: $2.25From: 2012-07-27Exp: 2017-07-27→ Common Stock (25,000 underlying)
Purchase
Warrant
2012-07-27$56250.00/sh+25,000$1,406,250,000→ 2,421,500 total(indirect: By Spouse)
Exercise: $2.25From: 2012-07-27Exp: 2017-07-27→ Common Stock (25,000 underlying)
Purchase
Convertible Note
2012-09-25$70000.00/sh+140,000$9,800,000,000→ 2,561,500 total
Exercise: $0.50From: 2012-09-25Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-09-25$150000.00/sh+300,000$45,000,000,000→ 2,861,500 total
Exercise: $0.50From: 2012-09-25Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-09-25$150000.00/sh+300,000$45,000,000,000→ 2,861,500 total(indirect: By Spouse)
Exercise: $0.50From: 2012-09-25Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-09-25$68216.00/sh+136,432$9,306,845,312→ 2,997,932 total
Exercise: $0.50From: 2012-09-25Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-11-30$325000.00/sh+650,000$211,250,000,000→ 3,647,932 total
Exercise: $0.50From: 2012-11-30Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-11-30$275000.00/sh+550,000$151,250,000,000→ 4,197,932 total
Exercise: $0.50From: 2012-11-30Exp: 2013-05-31→ Common Stock
Purchase
Convertible Note
2012-11-30$275000.00/sh+550,000$151,250,000,000→ 4,197,932 total(indirect: By Spouse)
Exercise: $0.50From: 2012-11-30Exp: 2013-05-31→ Common Stock
Award
Stock Option
2012-11-30$88000.00/sh+44,000$3,872,000,000→ 4,241,932 total
Exercise: $2.00From: 2012-11-30Exp: 2022-11-30→ Common Stock (44,000 underlying)
Award
Stock Option
2012-12-31$2200.00/sh+4,000$8,800,000→ 4,245,932 total
Exercise: $0.55From: 2012-12-31Exp: 2022-12-31→ Common Stock (4,000 underlying)
Award
Stock Option
2013-01-31$2200.00/sh+4,000$8,800,000→ 4,249,932 total
Exercise: $0.55From: 2013-01-31Exp: 2023-01-31→ Common Stock (4,000 underlying)
Award
Stock Option
2013-02-28$2200.00/sh+4,000$8,800,000→ 4,253,932 total
Exercise: $0.55From: 2013-02-28Exp: 2023-02-28→ Common Stock (4,000 underlying)

Footnotes (6)

[F1]On December 27, 2011 the Company issued to Virginia Child, wife of Stanley Hostler, 50,000 shares of common stock and warrants to purchase 25,000 shares of common stock exercisable at $2.25 per share.
[F2]Reissuance of stock certificates of previously issued shares.
[F3]On July 27, 2012, the Company issued 75,000 shares of common stock at $2.00 per share and five-year warrants of 37,500 to purchase additional shares of common stock for an aggregate purchase price of $150,000 to Stanley Hostler and Virginia Child, 25,000 shares and 12,500 warrants and 50,000 shares 25,000 warrants, respectively. The warrants are exercisable at an exercise price of $2.25 per share.
[F4]Transfer of shares previously held by the Reporting Person and his wife, Virginia Child, via Grantor Retained Annuity Trusts.
[F5]On December 20, 2011, the Company issued promissory notes to the Reporting Person equal to $250,000. On April 16, 2012, the Company issued a promissory note equal to $240,000 to the Reporting Person and Virginia Child. On September 25, 2012, the Company issued promissory notes equal to $288,216 to the Reporting Person and Virginia Child. On November 30, 2012, the Company issued promissory notes equal to $600,000 to the Reporting Person and Virginia Child. Each $2.00 of outstanding principal and accrued unpaid interest is convertible into one share of common stock . On March 22, 2013, the Company approved adjustment of conversion price of the notes from $2.00 to $0.50 per share. In accordance with Conversion Agreements, as of June 30, 2013 the $1,517,573 in principal and accrued unpaid interest were converted into common stock of the Company. In addition, the Company issued a 5-year warrant to each note holder to purchase 75% of the number of shares into which the notes converted
[F6]Represents share of record owned by the Reporting Person's wife, Virginia Child.

Documents

1 file

4
v368592_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Protea Biosciences Group, Inc.

CIK 0001335103

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001335103

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 8:47 PM ET
Size: 101.8 KB

View on SEC.gov